NCT06014580Completed
Molecular and Epidemiological Characteristics of Endometrial Cancer in Brazil
Source: ClinicalTrials.gov · Last updated 27 Aug 2026
Brief summary (registry, in English)
An evaluation of the molecular and epidemiological aspects of endometrial cancer in Brazil is necessary to understand the high frequency of advanced disease. A better understanding of the current situation will generate essential data for the future development of national or international cooperative programs that aim to improve outcomes in these patients and generate additional knowledge for much-needed clinical trials in this population.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 276 (actual)
- First submitted
- 15 Jun 2023
- Start date
- 27 Nov 2023
- Primary completion date
- 31 Oct 2024
- Lead sponsor
- Latin American Cooperative Oncology Group
- Diseases
- Endometrial cancer
- NCT number
- NCT06014580
What you commit to
- Study type: Observational
- Participants enrolled: 276
- From 27 Nov 2023 to the primary completion date, 31 Oct 2024
- 10 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with a history of concurrent or previously treated non-endometrial malignancies except for appropriately treated 1) non -metastatic non-melanoma skin cancer and/or 2) non-metastatic low-grade thyroid tumors and/or 3) in situ carcinomas, including cervix, colon, and skin.
Other illness
- Noninvasive endometrial cancer.
Other
- Nonepithelial histology (leiomyosarcoma, adenosarcoma, endometrial stromal sarcoma, undifferentiated sarcoma, or other mesenchymal tumors.
Who the study is looking for
- Women ≥18 years
- Histological diagnosis of endometrial carcinoma.
- Diagnosis of endometrial cancer between January 2016 and December 2019.
- FIGO (International Federation of Gynecology and Obstetrics, 2018) Stage I - IV.
- Site and investigator with access to a medical record chart from which data can be abstracted.
- Presence of a sample of tumor tissue (primary tumor or metastasis) available for biomarker testing.
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (10)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Evangélico de Cachoeiro de Itapemirim - Centro de Pesquisas Clínicas em Oncologia (CPCO) Coordinator of this site? Confirm its status | Cachoeiro de Itapemirim | Brazil | Unknown status |
| Clínica Prognóstica - Centro de Pesquisa Clínica Onconeo Coordinator of this site? Confirm its status | Campo Grande | Brazil | Unknown status |
| UOPECCAN - Hospital do Câncer de Cascavel Coordinator of this site? Confirm its status | Cascavel | Brazil | Unknown status |
| Santa Casa de Misericórdia de Feira de Santana Coordinator of this site? Confirm its status | Feira de Santana | Brazil | Unknown status |
| ICC - Instituto do Câncer do Ceará Coordinator of this site? Confirm its status | Fortaleza | Brazil | Unknown status |
| Hospital Napoleão Laureano Coordinator of this site? Confirm its status | João Pessoa | Brazil | Unknown status |
| INCA - Instituto Nacional de Câncer Coordinator of this site? Confirm its status | Rio de Janeiro | Brazil | Unknown status |
| Hospital de Oncologia do Maranhão Dr. Tarquínio Lopes Filho Coordinator of this site? Confirm its status | São Luís | Brazil | Unknown status |
| BP - A Beneficência Portuguesa de São Paulo Coordinator of this site? Confirm its status | São Paulo | Brazil | Unknown status |
| Instituto do Câncer Brasil - Unidade Três Lagoas Coordinator of this site? Confirm its status | Três Lagoas | Brazil | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.